Business Wire

Airbus Launches Airspace Link HBCplus – The Flexible High Bandwidth Connectivity Solution for Airlines

14.6.2022 12:30:00 EEST | Business Wire | Press release

Share

Airbus has launched Airspace Link HBCplus, its new flexible satellite connectivity solution that will be offered as an SFE* line-fit catalogue option and also for retrofit on all Airbus programmes. HBCplus, which initially encompasses Ka-band services, will enable airlines to connect to a choice of Managed Service Providers (MSPs) via a new certified terminal and radome built as part of the aircraft. In the future it is planned to extend HBCplus to include MSPs which offer Ku-band services.

Andre Schneider, Airbus VP Cabin & Cargo Programme said: “We are excited to offer airlines a new connectivity service solution that will provide improved speed and reliability for passenger experience and more flexibility. Together with our leading industry partners we are pleased to enable future connectivity business opportunities in the context of the Airspace Link open ecosystem.”

To this end Airbus has selected connectivity satcom leader Inmarsat as the first MSP, contributing its GX Aviation inflight broadband solution which offers reliable and seamless passenger experience with global coverage and capacity for future growth. Additional MSPs will join the HBCplus offering in due course.

Philippe Carette, President of Inmarsat Aviation, said: “We are honoured that Airbus has chosen Inmarsat as the first Managed Service Provider for this transformative connectivity catalogue solution and is putting its trust in our award-winning GX Aviation service across all of its aircraft programmes. Inmarsat looks forward to working closely with our partners Airbus and SPI to deliver continuous innovation for airlines and their passengers worldwide.”

Meanwhile Safran Passenger Innovations (SPI) has been selected as the terminal provider and hardware integrator of ThinKom’s proven antenna technology - targeted for Ka-band services which delivers high data throughput and reliability combined with aircraft fuel savings thanks to the antenna’s lower drag radome.

Matt Smith, CEO, Safran Passenger Innovations, said: “Safran Passenger Innovations is delighted to be selected as the equipment supplier for Airbus’ Airspace Link connectivity solution. We are excited to be a part of the next evolution in the IFC industry by providing the technology for airlines to select the connectivity services most suited to their needs. We look forward to working with Airbus and our partners on this industry-changing endeavour.”

Airspace Link HBCplus thus provides satcom based off-board connectivity for the Airspace Link open ecosystem representing an end-to-end Airbus offer. This solution, which enables the exchange of data as one seamlessly integrated aircraft system, is ideally positioned to unlock future digital services capacity and demand growth, allowing airlines to deliver a best in class passenger connectivity experience, in an exponentially growing market.

SFE* = Supplier Furnished Equipment

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Martin FENDT
Airbus
+33 (0)6 29 54 27 03 martin.fendt@airbus.com

Lois BENQUET
Airbus
+33 (0)6 42 88 10 65 lois.benquet@arbus.com

Jared SIQUELAND
Safran Passenger Innovations
+1 714 203 0525 jared.siqueland@zii.aero

Robeel HAQ
Inmarsat Aviation
+44 (0)207 728 1352 robeel.haq@inmarsat.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Bureau Veritas: A Steady Organic Revenue Growth in the First Quarter 202622.4.2026 08:30:00 EEST | Press release

Bureau Veritas (BOURSE:BVI): Q1 2026 Key figures1 › Revenue of EUR 1,547.0 million, up 4.5% organically, and down 0.8% year-on-year › Strong organic growth from Marine & Offshore at +11.2% and Buildings & Infrastructure at +7.3% with moderate growth for Consumer Products Services at +4.3%, Certification at +2.3%, Agri-Food & Commodities at +2.1%, and Industry at +0.7%, › Stable scope effect of (0.1)%, from bolt-on acquisitions (+1.8% contribution), net of disposals (-1.9%), › Negative currency impact of 5.2%, resulting from the euro’s appreciation against most currencies. Q1 2026 Highlights › Maintained steady performance across most regions, in an environment marked by disruptions related to the conflict in the Middle East; growth in the Industry business impacted by the delays of Opex-related services mainly in the Middle East, › Continued progress in execution of the Group’s LEAP | 28 strategy, pivoting its portfolio towards higher‑growth and higher‑margin activities. Four acquisiti

Bureau Veritas: A Steady Organic Revenue Growth in the First Quarter 202622.4.2026 08:30:00 EEST | Press release

Bureau Veritas (BOURSE:BVI): Q1 2026 Key figures1 › Revenue of EUR 1,547.0 million, up 4.5% organically, and down 0.8% year-on-year › Strong organic growth from Marine & Offshore at +11.2% and Buildings & Infrastructure at +7.3% with moderate growth for Consumer Products Services at +4.3%, Certification at +2.3%, Agri-Food & Commodities at +2.1%, and Industry at +0.7%, › Stable scope effect of (0.1)%, from bolt-on acquisitions (+1.8% contribution), net of disposals (-1.9%), › Negative currency impact of 5.2%, resulting from the euro’s appreciation against most currencies. Q1 2026 Highlights › Maintained steady performance across most regions, in an environment marked by disruptions related to the conflict in the Middle East; growth in the Industry business impacted by the delays of Opex-related services mainly in the Middle East, › Continued progress in execution of the Group’s LEAP | 28 strategy, pivoting its portfolio towards higher‑growth and higher‑margin activities. Four acquisiti

4Moving Biotech Granted FDA Fast Track Designation to 4P004, Supporting an Accelerated Development Pathway in Knee Osteoarthritis22.4.2026 08:00:00 EEST | Press release

4Moving Biotech (4MB), a clinical-stage biotechnology company developing next-generation Disease-Modifying Osteoarthritis Drugs (DMOADs), today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to 4P004 for the treatment of knee osteoarthritis in patients with synovitis who have not benefited from at least two prior pharmacological therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260421591087/en/ 4Moving Biotech Granted FDA Fast Track Designation to 4P004, Supporting an Accelerated Development Pathway in Knee Osteoarthritis This designation highlights both the serious burden of knee osteoarthritis and the persistent lack of disease-modifying treatment options. It also reflects the strong scientific rationale supporting the 4P004 development program, including its targeted intra-articular approach and the role of synovitis as a key marker of disease progression. 4P004 is a

4Moving Biotech Granted FDA Fast Track Designation to 4P004, Supporting an Accelerated Development Pathway in Knee Osteoarthritis22.4.2026 08:00:00 EEST | Press release

4Moving Biotech (4MB), a clinical-stage biotechnology company developing next-generation Disease-Modifying Osteoarthritis Drugs (DMOADs), today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to 4P004 for the treatment of knee osteoarthritis in patients with synovitis who have not benefited from at least two prior pharmacological therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260421591087/en/ 4Moving Biotech Granted FDA Fast Track Designation to 4P004, Supporting an Accelerated Development Pathway in Knee Osteoarthritis This designation highlights both the serious burden of knee osteoarthritis and the persistent lack of disease-modifying treatment options. It also reflects the strong scientific rationale supporting the 4P004 development program, including its targeted intra-articular approach and the role of synovitis as a key marker of disease progression. 4P004 is a

LTM Wins Two Google Cloud Partner of the Year Awards for 202622.4.2026 05:30:00 EEST | Press release

LTM, the Business Creativity partner to the world’s largest enterprises, announced today that it has received two Google Cloud Partner of the Year 2026 Awards. LTM is being recognized for its achievements in the Google Cloud ecosystem, helping joint customers to drive high-impact, scalable cloud transformations. LTM won the Google Cloud Partner of the Year Award in the Media & Entertainment category by modernizing a global media company's complex data estate with BigQuery. The transformation improved speed, lowered costs, and provided a scalable foundation, enabling real-time analytics and AI-ready pipelines. This approach offers a repeatable model for data modernization in Media and Entertainment industry. Additionally, LTM was honoured with another Google Cloud Partner of the Year Award for Infrastructure Modernization in North America and the transformation of the ERP landscape for a global leader in healthcare services. This resulted in faster time to market, modern scalable ecosys

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye